|
Development of Transporter Targeted Platinum Drugs for Glioblastoma
|
1R43CA177013-01A1
|
$216,990
|
$216,990
|
CHIEN, HUAN-CHIEH
|
APRICITY THERAPEUTICS, INC.
|
|
The Sox9/NFIA Transcriptional Network In Malignant Glioma
|
5K01CA190235-02
|
$140,400
|
$140,400
|
GLASGOW, STACEY
|
BAYLOR COLLEGE OF MEDICINE
|
|
Cognitive Change after Proton RT vs. Photon or Surgery for Pediatric Brain Tumor
|
5R01CA187202-03
|
$102,827
|
$102,827
|
KAHALLEY, LISA
|
BAYLOR COLLEGE OF MEDICINE
|
|
(PQD-5) Patient derived orthotopic xenograft models for drug response prediction
|
5R01CA185402-03
|
$322,828
|
$322,828
|
LI, XIONAN
|
BAYLOR COLLEGE OF MEDICINE
|
|
In Vivo Drug Testing of Pediatric CNS Tumors Using Patient Derived Orthotopic Xenograft Models
|
5U01CA199288-02
|
$578,693
|
$578,693
|
LI, XIONAN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S1
|
$118,016
|
$5,901
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S2
|
$170,897
|
$8,545
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S3
|
$118,875
|
$5,944
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S4
|
$499,947
|
$24,997
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S5
|
$134,220
|
$6,711
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-10
|
$3,253,119
|
$162,656
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
A Phase I Study of Intracranially Administered Carboxylesterase-Expressing Neural Stem Cells in Combination with Intravenous Irinotecan in Patients with Recurrent High Grade Gliomas
|
5R01CA198076-02
|
$618,770
|
$618,770
|
PORTNOW, JANA
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-33S1
|
$125,651
|
$3,770
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-33S2
|
$124,999
|
$3,750
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-33S3
|
$37,400
|
$1,122
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-33S4
|
$350,000
|
$10,500
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
4P30CA033572-33
|
$2,520,000
|
$75,600
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
(PQB5)Molecular Wiring and Therapeutic Targeting of EGFR and PDGFR Signaling Netw
|
7R01CA185137-03
|
$918,872
|
$918,872
|
CHAREST, ALAIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
BMX-001 as a Therapeutic Agent for Treatment of High-Grade Gliomas
|
5R44CA195749-02
|
$1,023,555
|
$1,023,555
|
CRAPO, JAMES
|
BIOMIMETIX JV, LLC
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-03S1
|
$1,595,651
|
$39,891
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-03S2
|
$550,000
|
$13,750
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-03S3
|
$750,000
|
$18,750
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
5U10CA180821-03
|
$9,068,022
|
$226,701
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Indirubins: novel anti-invasive and anti-angiogenic drugs for malignant gliomas
|
4R01CA166172-04
|
$368,313
|
$368,313
|
CHIOCCA, E.
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Investigating the cytomegalovirus link to glioblastoma using a novel mouse model
|
5R01CA195532-02
|
$377,464
|
$377,464
|
CHIOCCA, E.
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
MicroRNA128 Regulation of Polycomb Repressor Complexes1 and 2 in Glioblastoma
|
5R01CA176203-03
|
$337,527
|
$337,527
|
GODLEWSKI, JAKUB
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Resting-state fMRI for Language Mapping in Brain Tumor Patients
|
5R21CA198740-02
|
$193,031
|
$193,031
|
GOLBY, ALEXANDRA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Quantitative Image Informatics for Cancer Research (QIICR)
|
3U24CA180918-04S1
|
$257,375
|
$84,934
|
KIKINIS, RON
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Quantitative Image Informatics for Cancer Research (QIICR)
|
4U24CA180918-04
|
$668,889
|
$220,733
|
KIKINIS, RON
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
MRI-guided focused ultrasound for drug delivery and ablation of brain tumors
|
4P01CA174645-04
|
$1,217,277
|
$815,576
|
MCDANNOLD, NATHAN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Open source diffusion MRI technology for brain cancer research
|
5U01CA199459-02
|
$368,313
|
$368,313
|
O'DONNELL, LAUREN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Center of Excellence for High Throughput Proteogenomic Characterization
|
1U24CA210986-01
|
$1,288,045
|
$425,055
|
CARR, STEVEN
|
BROAD INSTITUTE, INC.
|
|
Proteo-genomic Discovery, Prioritization and Verification of Cancer Biomarkers
|
3U24CA160034-05S1
|
$825,543
|
$206,386
|
CARR, STEVEN
|
BROAD INSTITUTE, INC.
|
|
Nanosystems Biology Cancer Center
|
5U54CA199090-02
|
$2,446,594
|
$1,786,014
|
HEATH, JAMES
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
|
Targeting Brain Tumor Stem Cells In The Hypoxic Microenvironment
|
5R01CA187780-02
|
$362,569
|
$362,569
|
BAR, ELI
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Loss of Fractalkine Signaling Affects CNS Tumor Growth via Microglia Interactions
|
5F31CA196265-02
|
$29,633
|
$29,633
|
DORAND, RODNEY
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-26S1
|
$20,833
|
$3,542
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-26S2
|
$60,000
|
$10,200
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-26S3
|
$118,406
|
$20,129
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-26S4
|
$200,000
|
$34,000
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
4P30CA043703-26
|
$4,895,515
|
$832,238
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Treatment of glioblastoma using chain-like nanoparticles
|
5U01CA198892-02
|
$724,308
|
$724,308
|
KARATHANASIS, EFSTATHIOS
|
CASE WESTERN RESERVE UNIVERSITY
|
|
CWRU Case Comprehensive Cancer Center NCTN Lead Academic Participating Site
|
5U10CA180853-03
|
$1,033,213
|
$51,661
|
MACHTAY, MITCHELL
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Polyamine Catabolism and Therapeutic Resistance in Glioblastoma Multiforme
|
5R01CA187053-02
|
$361,136
|
$361,136
|
WELFORD, SCOTT
|
CASE WESTERN RESERVE UNIVERSITY
|
|
A Genetic Toolbox for the Identification and Interrogation of Tumor Cells of Origin, Propagation, and Recurrence From Patient-derived Oncogenic Drivers
|
1R33CA202900-01
|
$418,128
|
$418,128
|
BREUNIG, JOSHUA
|
CEDARS-SINAI MEDICAL CENTER
|
|
Glial tumor image-guided surgery and treatment
|
1R01CA209921-01
|
$544,935
|
$544,935
|
HOLLER, EGGEHARD
|
CEDARS-SINAI MEDICAL CENTER
|
|
Nanoconjugate delivery of proliferation and checkpoint inhibitors to treat glial tumors
|
1R01CA206220-01
|
$557,887
|
$557,887
|
LJUBIMOVA, JULIA
|
CEDARS-SINAI MEDICAL CENTER
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-03S1
|
$3,025,319
|
$680,697
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Solid Malignancy Integrated Translational Science Center
|
5U10CA180884-03
|
$400,000
|
$80,000
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
5U10CA180886-03
|
$21,084,883
|
$4,744,099
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
Total relevant funding to Brain for this search: $194,189,633
|